Hospital Universitari Son Dureta Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Mallorca Spain (1955)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2000
NCT00560053
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Hospital Son Dureta | Hospital Son Dureta de Mallorca | Hospital Son Dureta, Mallorca, Spain | Hospital Son Dureta Palma de Mallorca | Hospital Son Dureta. Stroke Unit. | Hospital Universitario Son Dureta | Son Dureta Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aortic Valve Stenosis (Phase 3)

Brain Injuries (Phase 3)

Brain Injuries, Traumatic (Phase 3)

Calcinosis (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 2)

Colorectal Neoplasms (Phase 2)

Heart Valve Diseases (Phase 3)

HIV Infections (Phase 3)

Hypertension (Phase 3)

Intracranial Hypertension (Phase 3)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Multiple Myeloma (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Obstetric Labor, Premature (Phase 3)

Ovarian Neoplasms (Phase 2)

Premature Birth (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Stroke (Phase 4)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 26